Mallinckrodt Skips Bond Interest Bill While Mulling Options
By Jeff Montgomery · June 15, 2023, 3:28 PM EDT
Pharmaceutical giant Mallinckrodt PLC disclosed to regulators Thursday that it will skip interest payments due on $1.025 billion in senior secured note obligations as the company weighs options while under growing...
To view the full article, register now.